SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 297 filers reported holding SEATTLE GENETICS INC in Q2 2018. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $9,000 | +12.5% | 105 | 0.0% | 0.01% | +20.0% |
Q2 2019 | $8,000 | -68.0% | 105 | -69.2% | 0.01% | -70.6% |
Q1 2019 | $25,000 | +31.6% | 341 | 0.0% | 0.02% | +21.4% |
Q4 2018 | $19,000 | -24.0% | 341 | +4.9% | 0.01% | -6.7% |
Q3 2018 | $25,000 | +13.6% | 325 | 0.0% | 0.02% | +7.1% |
Q2 2018 | $22,000 | +46.7% | 325 | +14.4% | 0.01% | +55.6% |
Q1 2018 | $15,000 | 0.0% | 284 | 0.0% | 0.01% | 0.0% |
Q4 2017 | $15,000 | -28.6% | 284 | -25.1% | 0.01% | -30.8% |
Q3 2017 | $21,000 | +5.0% | 379 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $20,000 | -16.7% | 379 | +0.3% | 0.01% | -18.8% |
Q1 2017 | $24,000 | +20.0% | 378 | 0.0% | 0.02% | +23.1% |
Q4 2016 | $20,000 | -61.5% | 378 | -61.0% | 0.01% | -63.9% |
Q3 2016 | $52,000 | +33.3% | 970 | 0.0% | 0.04% | +28.6% |
Q2 2016 | $39,000 | +39.3% | 970 | +22.5% | 0.03% | +55.6% |
Q1 2015 | $28,000 | +12.0% | 792 | 0.0% | 0.02% | +12.5% |
Q4 2014 | $25,000 | +19.0% | 792 | +40.4% | 0.02% | +6.7% |
Q3 2014 | $21,000 | -4.5% | 564 | 0.0% | 0.02% | 0.0% |
Q2 2014 | $22,000 | – | 564 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parametrica Management Ltd | 3,581 | $248,000 | 42.18% |
Baker Brothers Advisors | 50,057,277 | $3,464,464,000 | 23.54% |
Lagoda Investment Management, L.P. | 76,073 | $5,265,000 | 6.10% |
Matrix Capital Management Company, LP | 3,141,852 | $217,448,000 | 4.02% |
DOMINI IMPACT INVESTMENTS LLC | 3,111 | $215,000 | 2.98% |
Opus Point Partners Management, LLC | 17,901 | $1,239,000 | 1.83% |
EMORY UNIVERSITY | 33,593 | $2,325,000 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,215,000 | 1.56% |
Capital International Sarl | 130,400 | $9,025,000 | 1.26% |
CAPITAL GUARDIAN TRUST CO | 1,303,961 | $90,147,000 | 1.21% |